Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro

Free Radical Biology and Medicine

Volumn 25, Issue 7, 1998, Pages 839-847

  Schlotte, Volkhard ^a   Sevanian, Alex ^b   Hochstein, Paul ^b   Weithmann, K Ulrich ^a  

^a SANOFI   (France)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Tocopherol; Antioxidants; Atherosclerosis; Free radical; LDL oxidation; PUFA oxidation; Purine; Uric acid; Xanthine

Indexed keywords

LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID; URIC ACID;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; LIPID OXIDATION; LIPOPROTEIN METABOLISM; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

ANTIOXIDANTS; ARACHIDONIC ACIDS; BETA CAROTENE; CHOLESTEROL ESTERS; COPPER; FATTY ACIDS, UNSATURATED; HUMANS; KINETICS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PURINES; URIC ACID; VITAMIN E; XANTHINE;

EID: 0032212580     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00160-9     Document Type: Article

References (34)

1. Marx J.L. Oxygen free radicals linked to many disease. Science. 235:1987;529-531.
2. Halliwell B., Gutteridge J.M.C. Free radical and antioxidant protection: mechanisms and significance in toxicology and disease. Human Toxicol. 7:1988;7-18.
3. Marciniak G., Petty M.A. Design and biological evaluation of new antioxidants for use in cerebrovascular disorders. Drugs Fut. 21:1996;1037-1046.
4. Kaur H., Edmonds S.E., Blake D.R., Halliwell B. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann. Rheum. Dis. 55:1996;915-920.
5. Halliwell B. Antioxidant characterization. Methodology and mechanism. Biochem. Pharmacol. 49:1995;1341-1348.
6. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer A hypothesis . Proc. Natl. Acad. Sci. USA. 78:1981;6858-6862.
7. Davies K.J.A., Sevanian A., Muakkassah-Kelly S.F., Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem. J. 235:1986;747-754.
8. Grome J.J., Stefanovich V. Differential effects of xanthine derivatives on local cerebral blood flow and glucose utilization in the conscious rat. Stefanovich V., Rudolphi K., Schubert P. Adenosine: Receptors and modulation of cell function. 1985;453-460 IRL Press, Oxford.
9. Nolte D. Theophyllin-mit hundert ins vierte Leben. Mediz. Klin. 89:1994;675-676.
10. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
11. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
12. Hughes T.A., Moore M.A., Neame P., Medley M.F., Chung B.H. Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high-performance liquid chromatography. J. Lipid Res. 29:1988;363-376.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-268.
14. Esterbauer H., Striegel G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
15. Esterbauer H., Jürgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes . J. Lipid Res. 28:1987;495-509.
16. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involving lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. 81:1984;3883-3887.
17. Lehmann J.L., Martin H.L. Improved measurement of α- and γ-tocopherol in plasma and platelets by liquid chromatography with fluorescence detection. Clin. Chem. 28:1982;1784-1787.
18. Vercaemst R., Union A., Rosseneu M. Separation and quantification of free cholesterol and cholesteryl esters in a macrophage cell line by high-performance liquid chromatography. J. Chromatogr. 494:1989;43-52.
19. Miller K.W., Yang C.S. An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, α-tocopherol and various carotenoids. Anal. Biochem. 145:1985;21-26.
20. Patel P.R., Svistunenko D., Wilson M.T., Darley-Usmar V.M. Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein. Biochem. J. 322:1997;425-433.
21. Palinski W., Rosenfeld M.E., Yla H.S., Gurtner G.C., Socher S.S., Butler S.W., Parthasaraty S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1676.
22. Rosenfeld M.E., Palinski W., Yla H.S., Carey T.E. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. Toxicol. Pathol. 18:1990;560-571.
23. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386:1997;73-77.
24. Lehr H.A., Hübner C., Finckh B., Angermüller S., Nolte D., Beisiegel U., Kohlschütter A., Messmer K. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J. Clin. Invest. 88:1991;9-14.
25. Smith R.C., Reeves J., McKee M.L., Daron H. Reactions of methylated urates with 1,1-diphenyl-2-picryl-hydrazyl. Free Radic. Biol. Med. 3:1987;251-257.
26. Maples K.R., Mason R.P. Free radical metabolite of uric acid. J. Biol. Chem. 263:1988;1709-1712.
27. Fraisse L., Verlhac J.B., Roche B., Rascle M.C., Rabion A., Seris J.L. Long-chain-substituted uric acid and 5,6-diaminouracil derivatives as novel agents against free radical processes Synthesis and in vitro activity . J. Med. Chem. 36:1993;1465-1473.
28. Nishida Y. Inhibition of lipid peroxidation by purines and analogues of purine. Sahota A., Taylor M. Purine and pyrimidine metabolism in man. 1995;303-306 Plenum Press, New York.
29. Smith C., Mitchinson J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:1992;901-905.
30. Garner B., van Reyk D., Dean R.T., Jessup W. Direct copper reduction by macrophages. J. Biol. Chem. 272:1997;6927-6935.
31. Sato K., Niki E., Shimasaki H. Free radical- mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophys. 279:1990;402-405.
32. Schönharting M., Musikic P., Müller R. The haemorheological and antithrombotic potential of pentoxifylline A review . Pharmatherapeutica. 5:1988;159-169.
33. Cornish H.H., Christman A.A. A study of the metabolism of theobromine, theophylline and caffeine in man. J. Biol. Chem. 228:1957;315-323.
34. Currie M.S., Rao K.M.K., Padmanabhan J., Jones A., Crawford J., Cohen J. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J. Leukocyte Biol. 47:1990;244-250.